REGISTERED NUMBER: 04857038 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 January 2026

for

Prn Medical Transcription Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

D J Bijl

Mrs I P M Bijl

REGISTERED OFFICE:

4 Highfield Road

Malvern

England

Worcestershire

WR14 1HS

REGISTERED NUMBER:

04857038 (England and Wales)

ACCOUNTANTS:

Boyds Accountants

Britannia Court

5 Moor Street

Worcester

Worcestershire

WR1 3DB

CURRENT ASSETS

Debtors

4

4,091

4,109

Cash at bank

282,579

332,210

286,670

336,319

CREDITORS

Amounts falling due within one year

5

45,753

45,730

NET CURRENT ASSETS

240,917

290,589

TOTAL ASSETS LESS CURRENT LIABILITIES

240,917

290,589

CAPITAL AND RESERVES

Called up share capital

300

300

Capital redemption reserve

6

600

600

Retained earnings

6

240,017

289,689

SHAREHOLDERS' FUNDS

240,917

290,589

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 October 2026 and were signed on its behalf by:

D J Bijl - Director

1.	STATUTORY INFORMATION

Prn Medical Transcription Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.26

31.1.25

£

£

Tax

4,091

4,109

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.26

31.1.25

£

£

Social security and other taxes

20

20

VAT

13,415

13,415

Other creditors

30,365

30,365

Directors' current accounts

719

199

Accrued expenses

1,234

1,731

45,753

45,730

6.

RESERVES

Capital

Retained

redemption

earnings

reserve

Totals

£

£

£

At 1 February 2025

289,689

600

290,289

Profit for the year

78

78

Dividends

(49,750

)

(49,750

)

At 31 January 2026

240,017

600

240,617

7.	ULTIMATE CONTROLLING PARTY

The controlling party is D J Bijl.